Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo.
Chaves OA, Sacramento CQ, Ferreira AC, Mattos M, Fintelman-Rodrigues N, Temerozo JR, Vazquez L, Pinto DP, da Silveira GPE, da Fonseca LB, Pereira HM, Carlos AS, d'Avila JC, Viola JPB, Monteiro RQ, Bozza PT, Castro-Faria-Neto HC, Souza TML.
Chaves OA, et al. Among authors: vazquez l.
Pharmaceuticals (Basel). 2021 Dec 24;15(1):21. doi: 10.3390/ph15010021.
Pharmaceuticals (Basel). 2021.
PMID: 35056078
Free PMC article.